Source link : https://newshealth.biz/health-news/vixarelimab-safe-and-effective-in-prurigo-nodularis/
In a randomized clinical trial, vixarelimab demonstrates dose-dependent, long-term safety and efficacy in patients with prurigo nodularis. Medscape Medical News Source link : https://www.medscape.com/viewarticle/first-class-monoclonal-antibody-safe-effective-patients-2025a1000zg6?src=rss Author : Publish date : 2025-12-17 16:10:00 Copyright for syndicated content belongs to the linked Source.
The post Vixarelimab Safe and Effective in Prurigo Nodularis first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-17 16:10:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8